From Investing.com: 2024-11-19 09:20:33

Healthcare executives and investors anticipate increased IPOs and dealmaking in 2025, with geopolitical tensions posing the biggest risk, per Jefferies’ report. M&A activity is active, with notable deals like Johnson & Johnson’s acquisition of Shockwave Medical. 72% expect higher healthcare M&A levels, with North America dominating deals. Geopolitical risks and funding concerns are key issues.

Confidence in healthcare IPOs is high, with 64% expecting more in 2025. 20% believe equity financing and IPOs will dominate transactions, the highest since 2018. Weight loss drugs are predicted to have a large and sustainable impact. Novo Nordisk’s Wegovy sales exceeded expectations amid growing demand.

Market outlook is optimistic, with two-thirds believing Britain’s blue-chip index will rise by 2025. 73% expect the Healthcare Index to close higher as well. Respondents are bullish on market forecasts, signaling confidence in the healthcare sector’s future growth.



Read more at Investing.com: Healthcare executives expect more IPOs and corporate dealmaking in 2025 By Reuters